Shareholder Rights Law Firm Robbins LLP Urges EPIX Shareholders With Large Losses To Seek Counsel For The ESSA Pharma Inc. Class Action
About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LL have been dedicated to helping shareholders recover losses, improve corporate governance ...
Endovascular Today13h
Akura Begins Pivotal Trial of Katana Thrombectomy System in Pulmonary Embolism
Akura Medical, Inc., a privately held portfolio company of Shifamed LLC that is developing treatments for venous thromboembolis ...
Rezolute, Inc.: Rezolute Provides Update on its Phase 3 sunRIZE Study of Ersodetug for the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism
Open-label arm (infant participants DMC approved enrollment of infants into the double-blind portion of the study sunRIZE enrollment completion expected in Q2 2025, subject to outcomes from upcoming ...
Hosted on MSN17h
PFE's Colorectal Cancer Drug Meets Other Dual Primary Goal of PFS
Pfizer PFE announced positive top-line results from the progression-free survival (PFS) analysis of a late-stage study of its ...
Glucotrack reports success in first human glucose monitor trial
RUTHERFORD, N.J. - Glucotrack, Inc. (NASDAQ: GCTK), a medical technology company, announced the successful completion of its first in human clinical study for a novel continuous glucose monitoring ...
Veru To Present At The Oppenheimer 35Th Annual Healthcare Life Sciences Conference
About Veru Inc. Veru is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of cardiometabolic diseases, oncology, and ARDS. The Company's drug ...